Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis

Background: About a quarter of patients with locally advanced colon cancer (pT4) develop locoregional recurrence, including peritoneal metastases. The aim of this individual patient data meta-analysis (IPDMA) was to evaluate the efficacy of adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC)...

ver descrição completa

Detalhes bibliográficos
Autor: The COLOPEC and HIPECT4 Collaborator Groups
Formato: artículo
Fecha de publicación:2025
País:España
Recursos:Universidad de Málaga
Repositorio:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
Idioma:inglés
OAI Identifier:oai:ddfv.ufv.es:10641/6799
Acesso em linha:https://hdl.handle.net/10641/6799
Access Level:acceso abierto
Palavra-chave:Colorectal-cancer
Cytoreductive surgery
Curative treatment
Carcinomatosis
Survival
Management
Outcomes
Trials
Surgery
SDG 3 - Good Health and Well-being
Journal Article
Meta-Analysis
Systematic Review
yes
id ES_fc8097e8c74e14e46d31a8d923d706b7
oai_identifier_str oai:ddfv.ufv.es:10641/6799
network_acronym_str ES
network_name_str España
repository_id_str
spelling Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysisThe COLOPEC and HIPECT4 Collaborator GroupsColorectal-cancerCytoreductive surgeryCurative treatmentCarcinomatosisSurvivalManagementOutcomesTrialsSurgerySDG 3 - Good Health and Well-beingJournal ArticleMeta-AnalysisSystematic ReviewyesBackground: About a quarter of patients with locally advanced colon cancer (pT4) develop locoregional recurrence, including peritoneal metastases. The aim of this individual patient data meta-analysis (IPDMA) was to evaluate the efficacy of adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) with regard to reducing the locoregional recurrence rate in the overall population and high-risk subgroups of patients with locally advanced colon cancer. Methods: A systematic literature search was conducted in July 2024 to identify RCTs on adjuvant HIPEC in addition to routine adjuvant systemic chemotherapy in locally advanced colon carcinoma. An IPDMA was performed, with the locoregional recurrence rate as the primary endpoint and disease-free survival (DFS) and overall survival (OS) as secondary endpoints. Results: The search identified two trials (COLOPEC and HIPECT4). Individual patient data were pooled for 386 patients, of whom 189 patients received adjuvant HIPEC and 197 patients constituted the control group. The median follow-up was 36 (interquartile range 32-60) months. A modified intention-to-treat analysis showed a 36-month locoregional recurrence rate of 16.0% for HIPEC patients and 21.2% for control patients (P = 0.295). Predefined subgroup analyses revealed a significant reduction in locoregional recurrence after HIPEC in patients with right-sided tumours (HR 0.56 (95% c.i. 0.48 to 0.67)) (P < 0.001). No significant differences in survival were found for the overall study population; low event rates in subgroups did not allow for survival analyses. Conclusion: Adjuvant HIPEC significantly reduced the locoregional recurrence rate in right-sided locally advanced colon cancer, but not in the overall study population. Definitive conclusions on DFS and OS require longer follow-up.Facultad de Medicina20252025-04-0120252025-04-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10641/6799reponame:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoriainstname:Universidad de MálagaInglésengopen accesshttp://purl.org/coar/access_right/c_abf2http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:ddfv.ufv.es:10641/67992026-06-11T12:44:57Z
dc.title.none.fl_str_mv Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
title Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
spellingShingle Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
The COLOPEC and HIPECT4 Collaborator Groups
Colorectal-cancer
Cytoreductive surgery
Curative treatment
Carcinomatosis
Survival
Management
Outcomes
Trials
Surgery
SDG 3 - Good Health and Well-being
Journal Article
Meta-Analysis
Systematic Review
yes
title_short Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
title_full Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
title_fullStr Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
title_full_unstemmed Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
title_sort Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colon cancer at high risk of peritoneal metastases : Individual patient data meta-analysis
dc.creator.none.fl_str_mv The COLOPEC and HIPECT4 Collaborator Groups
author The COLOPEC and HIPECT4 Collaborator Groups
author_facet The COLOPEC and HIPECT4 Collaborator Groups
author_role author
dc.contributor.none.fl_str_mv Facultad de Medicina

dc.subject.none.fl_str_mv Colorectal-cancer
Cytoreductive surgery
Curative treatment
Carcinomatosis
Survival
Management
Outcomes
Trials
Surgery
SDG 3 - Good Health and Well-being
Journal Article
Meta-Analysis
Systematic Review
yes
topic Colorectal-cancer
Cytoreductive surgery
Curative treatment
Carcinomatosis
Survival
Management
Outcomes
Trials
Surgery
SDG 3 - Good Health and Well-being
Journal Article
Meta-Analysis
Systematic Review
yes
description Background: About a quarter of patients with locally advanced colon cancer (pT4) develop locoregional recurrence, including peritoneal metastases. The aim of this individual patient data meta-analysis (IPDMA) was to evaluate the efficacy of adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) with regard to reducing the locoregional recurrence rate in the overall population and high-risk subgroups of patients with locally advanced colon cancer. Methods: A systematic literature search was conducted in July 2024 to identify RCTs on adjuvant HIPEC in addition to routine adjuvant systemic chemotherapy in locally advanced colon carcinoma. An IPDMA was performed, with the locoregional recurrence rate as the primary endpoint and disease-free survival (DFS) and overall survival (OS) as secondary endpoints. Results: The search identified two trials (COLOPEC and HIPECT4). Individual patient data were pooled for 386 patients, of whom 189 patients received adjuvant HIPEC and 197 patients constituted the control group. The median follow-up was 36 (interquartile range 32-60) months. A modified intention-to-treat analysis showed a 36-month locoregional recurrence rate of 16.0% for HIPEC patients and 21.2% for control patients (P = 0.295). Predefined subgroup analyses revealed a significant reduction in locoregional recurrence after HIPEC in patients with right-sided tumours (HR 0.56 (95% c.i. 0.48 to 0.67)) (P < 0.001). No significant differences in survival were found for the overall study population; low event rates in subgroups did not allow for survival analyses. Conclusion: Adjuvant HIPEC significantly reduced the locoregional recurrence rate in right-sided locally advanced colon cancer, but not in the overall study population. Definitive conclusions on DFS and OS require longer follow-up.
publishDate 2025
dc.date.none.fl_str_mv 2025
2025-04-01
2025
2025-04-01
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10641/6799
url https://hdl.handle.net/10641/6799
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2

http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2

http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
instname:Universidad de Málaga
instname_str Universidad de Málaga
reponame_str DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
collection DDFV. Repositorio Institucional de la Universidad Francisco de Vitoria
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869425428364525568
score 15.812455